A newly funded study will seek to develop New Zealand’s first digital tool using AI technology to guide the safer use of
medicines in older adults and reduce the amount of harmful or unnecessary medicines prescribed.
Clinical pharmacy senior lecturer Dr Mohammed Mohammed from the University of Auckland has received an Emerging
Researcher First Grant from the Health Research Council of New Zealand (HRC) to develop this new digital tool, which
aims to help healthcare providers quickly and efficiently screen older New Zealanders at risk of over-, under- or
inappropriate prescribing.
Dr Mohammed is one of 24 up-and-coming researchers to receive Emerging Researcher First Grants from the HRC to a
combined value of $9.4 million. These grants support emerging talent to develop independent health research careers.
They are part of a suite of career development awards that includes student scholarships and postdoctoral fellowships,
the recently announced Māori and Pacific Health Research Emerging Leader Fellowships, as well as funding for healthcare
professionals and clinical researchers, all awarded through a competitive and robust peer-review process.
‘‘Medicines are the most common healthcare intervention, and they make up to a third of healthcare carbon emissions1.
Like many other developed countries, we have a growing ageing population in Aotearoa New Zealand. In just four years
from now, about 1 million2 people will be over the age of 65, with 1 in 3 taking five or more concurrent medicines,
known as polypharmacy,’’ says Dr Mohammed.
‘‘While medicines are very helpful for the prevention and treatment of health problems, inappropriate use can lead to a
range of problems such as falls, injuries, and hospitalisation in older adults. There are two major problems:
prescribing a medicine that is not quite right for an elderly person, which affects about 1 in 2 older people, and/or
omission of a medicine that is necessary, which affects about 1 in 3 older people,3’’ he says.
Dr Mohammed says automated clinical decision support tools can help healthcare providers to screen and manage patients
at risk of being prescribed inappropriate medicines and/or those not receiving the necessary medicines by consolidating
patient information from multiple health providers and data sources into one system.
He says currently, we don’t have a robust and efficient method that can identify the spectrum of these problems to
proactively screen individuals at risk of harm. Existing tools developed overseas do not account for the complexity of
medicine-related problems that older adults may experience and are also not directly applicable to New Zealand as they
don’t use New Zealand guidelines or pharmaceutical data.
With the help of this HRC funding, Dr Mohammed and his team will develop an all-in-one digital tool that will
intelligently analyse patient health information, identify individuals at risk of harm, and provide personalised
recommendations to healthcare providers at the point of care, such as alerting a doctor to start a new medicine that is
necessary or to stop a medicine that is causing harm or is not helping a patient.
“Ensuring that the tool is user-friendly is crucial, so we will seek feedback from healthcare providers and patients. We
will also embed key resources into the tool so that healthcare providers can give patients customised information such
as possible adverse withdrawal symptoms if a medicine is stopped and instructions for self-care,” says Dr Mohammed.
HRC Chief Executive Professor Sunny Collings says this research has the potential to transform the management of
medicines for older adults in New Zealand.
“Using innovative technology to support healthcare providers – particularly GP practices and hospitals – to offer
personalised, safer prescription services to our growing elderly population, and reduce medication errors and their
associated healthcare costs could greatly benefit our health system,” says Professor Collings.
See below for the full list of Emerging Researcher First Grant recipients. To read lay summaries of the recipients’
research projects, go to www.hrc.govt.nz/resources/research-repository and filter for ‘Emerging Researcher First Grants’, ‘2024’.
Recipients of the HRC’s 2024 Emerging Researcher First Grants
General category
Dr Priyanka Agarwal, the University of Auckland
Development of a topical treatment for management of chronic wounds
36 months, $400,000
Dr Recep Avci, the University of Auckland
Electromagnetic tracking system for the gut
36 months, $400,000
Dr Geke Aline Boer, University of Otago
Hypothalamic inhibition of GIPR signalling to increase health during ageing
27 months, $400,000
Dr Safina Gadeock, University of Otago
Interferon-alpha targets as prognostic biomarkers for IBD patients
36 months, $400,000
Dr Christopher Hedges, the University of Auckland
Understanding new targets for weight loss therapeutics
36 months, $399,844
Dr Sanjay Marasini, the University of Auckland
Light-assisted management of fungal keratitis
24 months, $400,000
Dr Mohammed Mohammed, the University of Auckland
AIM-Safer: Automated Intelligence for Safer Medication use in older adults
36 months, $399,990
Dr Mariana Muelbert, the University of Auckland
Antenatal corticosteroids effect on Lactation and Maternal-infant health (ALMA)
36 months, $399,972
Dr Amelia Power, the University of Auckland
Balancing heart energetics: Diabetes, Statins and Coenzyme Q10
36 months, $395,081
Dr Jamie-Lee Rahiri, Tuhauora Medical Associates
Haumanu Hauora - Determining the efficacy of bariatric surgery in Aotearoa
24 months, $288,945
Dr Vartika Sharma, the University of Auckland
Co-creating a parental resource with migrants to support youth mental health
36 months, $399,825
Dr Abigail Sharrock, Research Trust of Victoria University of Wellington
Engineering enzymes to enable CAR T-cells to synergise with chemotherapy
36 months, $400,000
Dr Marie-Claire Smith, the University of Auckland
Design of a rehabilitation model for cardiovascular health after stroke
36 months, $398,144
Dr Helen Waddell, University of Otago
Atrial fibrillation: linking heart cell structure to electrical function
36 months, $ 335,631
Dr Samuel Wardell, University of Otago
The role of antidepressants in promoting antibiotic resistance
30 months, $398,258
Dr George Wiggins, University of Otago
Advancing breast and ovarian cancer prevention strategies
36 months, $399,992
Dr Sandra Yellowhorse, the University of Auckland
Cultivating wellbeing by advancing Indigenous perspectives of autism
36 months, $399,866
Health Delivery category
Dr Sue Adams, the University of Auckland
Nurse practitioners: Re-prioritising primary care delivery to promote equity
30 months, $399,766
Dr Matthew Jenkins, University of Otago
Enhancing the health and wellbeing of rangatahi experiencing early psychosis
24 months, $399,975
Pacific category
Dr Sarah Kapeli, the University of Auckland
Pasifikmetrics: A psychometric measure of Pasifika mental health literacy
36 months, $399,977
Rangahau Hauora Māori category
Dr Eleanor Brittain, Massey University
A Kaupapa Māori behavioural health intervention for harmful substance use
36 months, $399,351
Dr Meri Haami, Tu Tama Wahine o Taranaki
He Whiringa Māramatanga: Kaupapa Māori music and healing
36 months, $377,550
Mr Logan Hamley, University of Waikato
Expanding connection: the process of reconnection for Māori youth
36 months, $400,000
Dr Monica Koia, Massey University
Timely access to rongoa Māori in cancer care services for Māori
36 months, $398,771